Lynn A. Tetrault - Oct 11, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
Lynn A. Tetrault
Stock symbol
NEO
Transactions as of
Oct 11, 2021
Transactions value $
$0
Form type
4
Date filed
10/13/2021, 05:04 PM
Previous filing
Jun 14, 2021
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +838 +2.4% $0.00 35.8K Oct 11, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +972 $0.00 972 Oct 11, 2021 Common Stock 972 $41.76 Direct
holding NEO Stock Option (Right to Buy) 3.33K Oct 11, 2021 Common Stock 3.33K $7.27 Direct F1
holding NEO Stock Option (Right to Buy) 1.51K Oct 11, 2021 Common Stock 1.51K $11.60 Direct
holding NEO Stock Option (Right to Buy) 2.14K Oct 11, 2021 Common Stock 2.14K $22.52 Direct
holding NEO Stock Option (Right to Buy) 3.45K Oct 11, 2021 Common Stock 3.45K $28.54 Direct
holding NEO Stock Option (Right to Buy) 3.71K Oct 11, 2021 Common Stock 3.71K $40.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.